Cargando…
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
Mutations in the glucocerebrosidase 1 (GBA1) gene are related to both Parkinson disease (PD) and Gaucher disease (GD). In both cases, the condition is associated with deficiency of glucocerebrosidase (GCase), the enzyme encoded by GBA1. Ambroxol is a small molecule chaperone that has been shown in m...
Autores principales: | Migdalska‐Richards, Anna, Ko, Wai Kin D., Li, Qin, Bezard, Erwan, Schapira, Anthony H. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485051/ https://www.ncbi.nlm.nih.gov/pubmed/28295625 http://dx.doi.org/10.1002/syn.21967 |
Ejemplares similares
-
Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016) -
The relationship between glucocerebrosidase mutations and Parkinson disease
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016) -
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
por: McNeill, Alisdair, et al.
Publicado: (2014) -
Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013) -
Local transgene expression and whole‐body transgenesis to model brain diseases in nonhuman primate
por: Chansel‐Debordeaux, Lucie, et al.
Publicado: (2019)